Gel Increases Success Rate of AVF Development
Researchers at the University of Alabama at Birmingham and Endomimetics, a biotechnology company, have showed that a self-assembling, nanomatrix gel that releases nitric oxide helped create a fully developed arteriovenous fistula (AVF) in rodents. The gel helps prevent overgrowth of cells at the anastomosis.
Read the full article » | Posted 01-14-2022
Related Articles
- Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026
- FDA granted 510(k) approval to Outset for Next generation Tablo with Cybersecurity Posted 02-17-2026
- Drs. Monica Farcus and Jeffrey Perl Win the Mitchell Award for Health System Innovation Posted 01-16-2026
- Nephrodite Wins FDA Breakthrough Device Designation for “Holly” Posted 01-16-2026

